• 13 Posts
  • 411 Comments
Joined 11 months ago
cake
Cake day: August 8th, 2023

help-circle
rss


  • The Democrats do not have a realistic chance of winning against Trump because the Democrats are entirely incapable of challenging power. It’s the fundamental contradiction of liberalism. They won’t do anything for the people they need to vote for them because if they do the people who fund them will stop funding them.

    Obama and Sanders both excelled at small-dollar donations, of course. Sadly, Obama was a silver-tongued coward and the Clinton Democrats made sure she didn’t repeat the mistakes of 2008 in 2016 by not bothering to sign up voters in case they killed her in the primaries again.

    They dig their own grave and they do so willingly because it makes them exceedingly rich.





  • Demanding that people vote for the least worst option without any content other than sneering at them for apparently not realising that one of the options is worse, is doing exactly that.

    It’s straw-manning the arguments of people who want (and desperately need) the Democrats to be better and are putting serious thought, time and energy into how that is possible in a world controlled by billionaires who unleash fascism the moment their power is threatened.

    And they’re doing it with a lazy, cynical, Bill Maher-wannabe take because apparently they think this is a good look?

    They’ll be the death of us all.
















  • It doesn’t cost that much because the company are making a hefty profit, of course. And much more profit off it in the US as per usual, the NHS pays considerably less

    The deal struck [in 2021] with Novartis Gene Therapies, secures the drug for NHS patients in England at a substantial confidential discount and paves the way for the National Institute for Health and Care Excellence (NICE) to publish draft guidance recommending treatment with Zolgensma.

    The terms of the deal mean that some young children that currently fall outside the NICE recommendation criteria will also be eligible to be considered for treatment by a national multidisciplinary clinical team (MDT) made up of the country’s leading experts in the treatment of SMA.

    This means as many as 80 babies and young children could potentially benefit from the life-changing gene therapy a year.

    But profiteering aside, the number in the final paragraph is your answer. Up to 80 kids in the UK per year, so up to ~400 in the US, ~500 for the EU. It’s not a big market but the cost of drug development doesn’t get cheaper just because the number of cases is small, it gets more difficult and more costly. And there’s more than one drug company chasing the market.

    None of that is a defence of Pharma. But it is inevitable under capitalism. Eat the rich etc etc.